If you're looking for a great AI stock under $10… you need to watch this right away. What the company is doing is pretty incredible. It could end up saving billions of lives… and billions of dollars. In short, the company is the creator of the first AI-designed drug to enter clinical trials. And this is a huge deal. Normally, bringing a new drug to market takes an average of 10 years and between $2.5 and $12 billion. However, new AI technology has the potential to make the process up to 1000 times faster. The Wall Street Journal reports that “the time required for the early stages of drug discovery could shrink from years to months.” Not only that, it has the potential to develop “never-before-seen molecules that could treat diseases like pancreatic cancer or ALS.” In short, this is groundbreaking stuff. And this #1 AI company is at the forefront of all of it. Get it here.
Alphabet Inc., the parent company of Google, has recently demonstrated a robust financial performance that underscores its potential as a long-term investment in the tech and AI sector. The company's shares rose nearly 5.5% following the announcement of its Q2 earnings, which exceeded market expectations, particularly in the realm of cloud computing.
Alphabet reported an adjusted earnings per share of $1.44, surpassing the Refinitiv survey of analysts' expectation of $1.34. The company's Q2 revenue was $74.6 billion, beating the consensus estimate of $72.82 billion.
Cloud Computing Growth:
A standout aspect of Alphabet's Q2 earnings was the significant growth in its cloud computing division, Google Cloud. The company reported $8.03 billion in Google Cloud sales, exceeding the StreetAccount consensus of $7.87 billion. This growth is particularly noteworthy as Google Cloud is in direct competition with industry giants Amazon Web Services and Microsoft Azure.
Moreover, Google's cloud unit reported its second consecutive quarter of operating profit, with Q2 operating income of $395 million, a significant turnaround from a $590 million loss in the year-ago quarter.
Goldman Sachs analyst Eric Sheridan highlighted Alphabet's leadership in AI investment over the past 5-6 years, positioning it well to capitalize on this trend in the coming decade. While there may be concerns about AI's impact on core products or cost structure, Alphabet's compounded AI investment and its potential returns cannot be overlooked.
Alphabet also announced a significant leadership change, with CFO Ruth Porat assuming a newly created position of President and Chief Investment Officer. This move indicates Alphabet's commitment to strategic investment and growth, further solidifying its position as a strong long-term investment.
Alphabet's strong Q2 earnings, significant growth in cloud computing, leadership in AI investment, and strategic leadership changes all point to a company that is well-positioned for sustained growth and innovation. As such, Alphabet presents a compelling investment opportunity for those looking to invest in the tech/AI sector for the long run.
A famous A.I. billionaire recently took center stage and shocked the world.
He left the crowd utterly speechless.
But what exactly happened?
He revealed a breakthrough device that will change everything you know about making money.
You won't see this story on the nightly news.